Medanta owner Global Health IPO: Subscription opens today: Check price band, allotment date and listing date

Global Health IPO Date, Price Band, Share Allotment Date, Listing Date: Global Health Limited's initial public offering (IPO) will open on Thursday, November 3, for subscriptions. The initial share sale will remain open for subscription till November 7. Global Health operates and manages hospitals under the Medanta brand. It has fixed a price band of Rs 319-336 a share for its Rs 2,206 crore IPO.

The IPO comprises fresh issuance of equity shares worth Rs 500 crore and an offer of sale up to 5.08 crore equity shares by promoters and existing shareholders. The face value of each share would be Rs 2. At the upper end of the price band, the company is expected to fetch Rs 2,206 crore through the IPO.

Half of the issue size has been reserved for qualified institutional investors, 35 per cent for retail investors and the remaining 15 per cent for non-institutional investors. Investors can bid for a minimum of 44 shares and in multiples thereof.

Global Health IPO allotment date

Global Health IPO allotted date is November 11.

Global Health IPO listing date

Global Health IPO will list on both the leading exchanges BSE and NSE. Global Health IPO listing date likely is November 16.

Government of Singapore, Nomura, Axis Mutual Fund (MF), HDFC MF, Aditya Birla Sun Life MF, SBI MF, ICICI Prudential MF, Kotak MF, Max Life Insurance Company and SBI Life

Insurance Company are among the anchor investors.

Ahead of the IPO, Global Health has mobilised Rs 662 crore from anchor investors that open for public subscription on Thursday. The company has decided to allocate 1.97 crore equity shares at Rs 336 apiece, aggregating the transaction size to about Rs 662 crore, according to a circular uploaded on the BSE website.

Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, Global Health is a leading private multi-specialty tertiary care provider in the north and east regions of India.

The company intends to capitalise on medical tourism, as part of its growth strategies.

The company delivered a total income of Rs 2,205.8 crore and a profit of Rs 196.2 crore in FY22.